SLC3A2 Gene

HGNC Family Solute carriers (SLC)
Name solute carrier family 3 (amino acid transporter heavy chain), member 2
Description This gene is a member of the solute carrier family and encodes a cell surface, transmembrane protein. The protein exists as the heavy chain of a heterodimer, covalently bound through di-sulfide bonds to one of several possible light chains. The encoded transporter plays a role in regulation of intracellular calcium levels and transports L-type amino acids. Alternatively spliced transcript variants, encoding different isoforms, have been characterized. [provided by RefSeq, Nov 2010]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC3A2, also known as CD98hc or 4F2hc, plays a central role as a membrane‐anchored regulatory protein that partners with integrins to amplify outside–in signaling. By physically associating with β1 integrins, SLC3A2 modulates key cellular processes such as cell spreading, adhesion, migration, survival, and T‐cell clonal expansion—processes that underlie both normal adaptive immunity and oncogenic transformation. Its overexpression is linked to aberrant integrin‐dependent activation of intracellular effectors including phosphatidylinositol 3‐kinase/Akt, focal adhesion kinase and Rac, thus promoting anchorage-independent growth and tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in integrin modulation, SLC3A2 is indispensable as the heavy chain subunit of heteromeric amino acid transporters. Its non‐covalent and disulfide‐bonded association with light chain partners (such as LAT1, LAT2 and others) is critical for the surface expression, stability, and function of these transporters. Structural studies using cryo–electron microscopy and biochemical analyses have revealed that SLC3A2 not only helps localize transporters to the plasma membrane but also contributes to the transmembrane flux of large neutral amino acids, thereby regulating nutrient uptake, metabolic reprogramming, and even glucose transporter (GLUT1) stabilization. These functions are crucial for sustaining cell growth and proliferation, particularly in cancer cells where altered nutrient metabolism supports rapid tumor expansion and survival."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond these biochemical roles, SLC3A2 is implicated in several developmental and tumor‐related contexts. In various cancers ranging from breast and colorectal to lung and osteosarcoma, its aberrant expression correlates with increased cell proliferation, migration, and poor clinical outcomes. Moreover, SLC3A2 serves as a key regulator in processes such as trophoblast fusion for placental development and as a fusion partner in oncogenic rearrangements (e.g. SLC3A2–NRG1) that drive aggressive tumor phenotypes. Its involvement in modulating epithelial–mesenchymal transition, cell invasion, and even interactions with other membrane proteins such as CD147 further highlight its multifunctional nature in regulating tumor progression and metastasis, as well as its potential as a prognostic marker and therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "29", "end_ref": "43"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of neurodevelopment, SLC3A2 is also differentially expressed in the fetal brain and placental tissues, suggesting that beyond its roles in nutrient transport and adhesion, it may influence cellular differentiation and developmental outcomes. Aberrant SLC3A2 expression in these settings has been linked to altered thyroid hormone distribution and amino acid homeostasis, with potential implications for neurodevelopmental disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "44"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Chloe C Feral, Naoyuki Nishiya, Csilla A Fenczik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98hc (SLC3A2) mediates integrin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0404852102"}], "href": "https://doi.org/10.1073/pnas.0404852102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15625115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15625115"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Joseph M Cantor, Mark H Ginsberg "}, {"type": "b", "children": [{"type": "t", "text": "CD98 at the crossroads of adaptive immunity and cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.096040"}], "href": "https://doi.org/10.1242/jcs.096040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22499670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22499670"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "David B Shennan, Jean Thomson "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18813831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18813831"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Robert C Rintoul, Robert C Buttery, Alison C Mackinnon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.01-11-0530"}], "href": "https://doi.org/10.1091/mbc.01-11-0530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12181350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12181350"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Neil C Henderson, Elizabeth A Collis, Alison C Mackinnon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M408700200"}], "href": "https://doi.org/10.1074/jbc.M408700200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15485886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15485886"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Joseph Cantor, Marina Slepak, Nil Ege, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1100002"}], "href": "https://doi.org/10.4049/jimmunol.1100002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21670318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21670318"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Songmin Cai, Nada Bulus, Priscila M Fonseca-Siesser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98 modulates integrin beta1 function in polarized epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.01674"}], "href": "https://doi.org/10.1242/jcs.01674"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15713750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15713750"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Aurélie Melchior, Agnès Denys, Audrey Deligny, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclophilin B induces integrin-mediated cell adhesion by a mechanism involving CD98-dependent activation of protein kinase C-delta and p44/42 mitogen-activated protein kinases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2007.11.007"}], "href": "https://doi.org/10.1016/j.yexcr.2007.11.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18054915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18054915"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yoshitaka Hirohata, Jun Arii, Zhuoming Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Herpes Simplex Virus 1 Recruits CD98 Heavy Chain and β1 Integrin to the Nuclear Membrane for Viral De-Envelopment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00741-15"}], "href": "https://doi.org/10.1128/JVI.00741-15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25995262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25995262"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yoshiki Kudo, C A R Boyd, J Millo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Manipulation of CD98 expression affects both trophoblast cell fusion and amino acid transport activity during syncytialization of human placental BeWo cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2003.040550"}], "href": "https://doi.org/10.1113/jphysiol.2003.040550"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12740424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12740424"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yutao Yan, Guillaume Dalmasso, Shanthi Sitaraman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00385.2006"}], "href": "https://doi.org/10.1152/ajpgi.00385.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17023546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17023546"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xia Liu, Laetitia Charrier, Andrew Gewirtz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98 and intracellular adhesion molecule I regulate the activity of amino acid transporter LAT-2 in polarized intestinal epithelia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M302777200"}], "href": "https://doi.org/10.1074/jbc.M302777200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12716892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12716892"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Renhong Yan, Xin Zhao, Jianlin Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-019-1011-z"}], "href": "https://doi.org/10.1038/s41586-019-1011-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30867591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30867591"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Mio Furuya, Jun Horiguchi, Hiroki Nakajima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2011.02151.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2011.02151.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22077314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22077314"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2008.00969.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2008.00969.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19018776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19018776"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Shuichi Okubo, Hai-Ning Zhen, Nobuyuki Kawai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-010-0117-9"}], "href": "https://doi.org/10.1007/s11060-010-0117-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20091333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20091333"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Lifang Ma, Xiao Zhang, Keke Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting SLC3A2 subunit of system X"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "C"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "-"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " is essential for m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2021.03.023"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2021.03.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33785413"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33785413"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yongchan Lee, Pattama Wiriyasermkul, Chunhuan Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41594-019-0237-7"}], "href": "https://doi.org/10.1038/s41594-019-0237-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31160781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31160781"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Joana Fort, Laura R de la Ballina, Hans E Burghardt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M704524200"}], "href": "https://doi.org/10.1074/jbc.M704524200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17724034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17724034"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Takeshi Uemura, Hagit F Yerushalmi, George Tsaprailis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and characterization of a diamine exporter in colon epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M804714200"}], "href": "https://doi.org/10.1074/jbc.M804714200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18660501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18660501"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Albert Rosell, Marcel Meury, Elena Álvarez-Marimon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1323779111"}], "href": "https://doi.org/10.1073/pnas.1323779111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24516142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24516142"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Chieh-Hsin Lin, Pei-Pei Lin, Chun-Yuan Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased mRNA expression for the two subunits of system xc(-), SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Psychiatr Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jpsychires.2015.10.007"}], "href": "https://doi.org/10.1016/j.jpsychires.2015.10.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26540405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26540405"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "David Digomann, Annett Linge, Anna Dubrovska "}, {"type": "b", "children": [{"type": "t", "text": "SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autophagy (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15548627.2019.1639302"}], "href": "https://doi.org/10.1080/15548627.2019.1639302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31276435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31276435"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Haruya Ohno, Yusuke Nakatsu, Hideyuki Sakoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4F2hc stabilizes GLUT1 protein and increases glucose transport activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00416.2010"}], "href": "https://doi.org/10.1152/ajpcell.00416.2010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21270293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21270293"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Benoît Malleret, Abbas El Sahili, Matthew Zirui Tay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Microbiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41564-021-00939-3"}], "href": "https://doi.org/10.1038/s41564-021-00939-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34294905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34294905"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Sara Cano-Crespo, Josep Chillarón, Alexandra Junza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-50547-9"}], "href": "https://doi.org/10.1038/s41598-019-50547-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31575908"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31575908"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Marcel Meury, Meritxell Costa, Daniel Harder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0109882"}], "href": "https://doi.org/10.1371/journal.pone.0109882"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25299125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25299125"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Annett Kühne, Rolf Kaiser, Markus Schirmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3280ea77cd"}], "href": "https://doi.org/10.1097/FPC.0b013e3280ea77cd"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17558306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17558306"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Dong Hoon Shin, Donghoon Lee, Dong Wan Hong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11913"}], "href": "https://doi.org/10.18632/oncotarget.11913"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27626312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27626312"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Paola Dalton, Helen C Christian, Christopher W G Redman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Membrane trafficking of CD98 and its ligand galectin 3 in BeWo cells--implication for placental cell fusion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2007.05806.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2007.05806.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17451431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17451431"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Rokaya El Ansari, Madeleine L Craze, Maria Diez-Rodriguez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-018-0038-5"}], "href": "https://doi.org/10.1038/s41416-018-0038-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29545595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29545595"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Marina Poettler, Matthias Unseld, Kira Braemswig, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-12-169"}], "href": "https://doi.org/10.1186/1476-4598-12-169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24359579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24359579"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Ryuichi Ohgaki, Takahiro Ohmori, Saori Hara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00427-16"}], "href": "https://doi.org/10.1128/MCB.00427-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28320871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28320871"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Fei Fei, Xiaofei Li, Li Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1245/s10434-014-3816-1"}], "href": "https://doi.org/10.1245/s10434-014-3816-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25084765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25084765"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Cuicui Sun, Ramin Zargham, Qin Shao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2014.06.016"}], "href": "https://doi.org/10.1016/j.prp.2014.06.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25041835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25041835"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Angélica Santiago-Gómez, Juan I Barrasa, Nieves Olmo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4F2hc-silencing impairs tumorigenicity of HeLa cells via modulation of galectin-3 and β-catenin signaling, and MMP-2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2013.04.017"}], "href": "https://doi.org/10.1016/j.bbamcr.2013.04.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23651923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23651923"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Yoshiki Kudo, C A R Boyd "}, {"type": "b", "children": [{"type": "t", "text": "RNA interference-induced reduction in CD98 expression suppresses cell fusion during syncytialization of human placental BeWo cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2004.10.047"}], "href": "https://doi.org/10.1016/j.febslet.2004.10.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15556631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15556631"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Xia Luo, Ping Yin, Scott Reierstad, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2009-1286"}], "href": "https://doi.org/10.1210/jc.2009-1286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19808856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19808856"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Moiz A Charania, Hamed Laroui, Hongchun Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Infect Immun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/IAI.01388-12"}], "href": "https://doi.org/10.1128/IAI.01388-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23297381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23297381"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Bin Zhu, Dongdong Cheng, Lei Hou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2017.5530"}], "href": "https://doi.org/10.3892/or.2017.5530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28350098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28350098"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Lutfi H Alfarsi, Rokaya El-Ansari, Madeleine L Craze, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21041407"}], "href": "https://doi.org/10.3390/ijms21041407"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32093034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32093034"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Kyoichi Kaira, Osamu Kawashima, Hedeki Endoh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2018.09.020"}], "href": "https://doi.org/10.1016/j.humpath.2018.09.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30300664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30300664"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Jailal N G Ablack, Patrick J Metz, John T Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubiquitylation of CD98 limits cell proliferation and clonal expansion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.178129"}], "href": "https://doi.org/10.1242/jcs.178129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26493331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26493331"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "S-Y Chan, A Martín-Santos, L S Loubière, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2011.207290"}], "href": "https://doi.org/10.1113/jphysiol.2011.207290"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21486766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21486766"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Lauren Cascio, Chin-Fu Chen, Rini Pauly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Abnormalities in the genes that encode Large Amino Acid Transporters increase the risk of Autism Spectrum Disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Genomic Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mgg3.1036"}], "href": "https://doi.org/10.1002/mgg3.1036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31701662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31701662"}]}]}]}
Synonyms 4F2HC, CD98HC, MDU1, 4F2, CD98, 4T2HC, NACAE
Proteins 4F2_HUMAN
NCBI Gene ID 6520
API
Download Associations
Predicted Functions View SLC3A2's ARCHS4 Predicted Functions.
Co-expressed Genes View SLC3A2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SLC3A2's ARCHS4 Predicted Functions.

Functional Associations

SLC3A2 has 15,546 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 130 datasets.

Click the + buttons to view associations for SLC3A2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by SLC3A2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC3A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC3A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC3A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SLC3A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC3A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC3A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC3A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SLC3A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with SLC3A2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with SLC3A2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC3A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SLC3A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SLC3A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC3A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SLC3A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SLC3A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing SLC3A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing SLC3A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SLC3A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SLC3A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing SLC3A2 protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SLC3A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SLC3A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SLC3A2 gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of SLC3A2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with SLC3A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SLC3A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SLC3A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SLC3A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SLC3A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC3A2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC3A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SLC3A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SLC3A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD High Level Gene-Disease Associations diseases associated with SLC3A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SLC3A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SLC3A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SLC3A2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SLC3A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC3A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SLC3A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC3A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SLC3A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SLC3A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding SLC3A2 protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2015 biological processes involving SLC3A2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SLC3A2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SLC3A2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SLC3A2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SLC3A2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SLC3A2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SLC3A2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SLC3A2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SLC3A2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SLC3A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SLC3A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with SLC3A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC3A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SLC3A2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SLC3A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SLC3A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SLC3A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for SLC3A2 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SLC3A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SLC3A2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SLC3A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SLC3A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SLC3A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate SLC3A2 protein from the curated KEA Substrates of Kinases dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC3A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC3A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with SLC3A2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SLC3A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SLC3A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SLC3A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC3A2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SLC3A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SLC3A2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SLC3A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SLC3A2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SLC3A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SLC3A2 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for SLC3A2 from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SLC3A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of SLC3A2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing SLC3A2 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SLC3A2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC3A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SLC3A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SLC3A2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SLC3A2 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with SLC3A2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate SLC3A2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving SLC3A2 protein from the PID Pathways dataset.
ProteomicsDB Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of SLC3A2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset.
Reactome Pathways 2014 pathways involving SLC3A2 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SLC3A2 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC3A2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC3A2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC3A2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SLC3A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC3A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC3A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SLC3A2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SLC3A2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with SLC3A2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of SLC3A2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs drug perturbations changing phosphorylation of SLC3A2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands ligand (protein) perturbations changing phosphorylation of SLC3A2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with SLC3A2 gene from the SynGO Synaptic Gene Annotations dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SLC3A2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of SLC3A2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SLC3A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SLC3A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SLC3A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SLC3A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC3A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SLC3A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC3A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SLC3A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SLC3A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving SLC3A2 protein from the WikiPathways Pathways 2024 dataset.